Boston Neuro Research is exploring new treatments for migraines, a common neurological condition characterized by intense headaches and other symptoms.

INCLUSIONS:

Participants eligible for the migraine study must meet the following criteria:

1. Diagnosis: Individuals must have a clinical diagnosis of chronic or episodic migraines.
2. Age: Participants should be aged 18 to 65 years.
3. Health Status: Stable medical conditions unrelated to migraines that do not interfere with study procedures.
4. Informed Consent: Participants must provide informed consent to join the study.

EXCLUSIONS:

Factors that may disqualify individuals from the migraine study include:

1. Severe Neurological Disorders: Presence of significant neurological disorders such as epilepsy.
2. Unstable Medical Conditions: Uncontrolled chronic illnesses such as severe cardiovascular disease.
3. Recent Participation: Involvement in other clinical trials within the past 30 days.
4. Psychiatric Disorders: Severe psychiatric conditions that could interfere with the study.

MEDICATIONS:

Participants in the migraine study will receive treatments including:

1. Triptans: Medications that relieve migraine symptoms.
2. Preventive Medications: Drugs used to reduce the frequency and severity of migraines.
3. Investigational Drugs: New treatments being tested for effectiveness and safety.
4. Adjunct Therapies: Additional treatments such as dietary changes and stress management techniques.

This study aims to provide new insights and treatments for those suffering from migraines.